Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, TRI, FVT

The 2nd AI Pharma Innovation: Drug Discovery Summit Is Back to San Francisco in February 27 ? 28, 2019


SAN FRANCISCO, November 13, 2018 /PRNewswire/ --

The 2nd AI-PI: Drug Discovery 2019 Summit returns to San Francisco, February 27 - 28, 2019. Key decision makers from pharma, biotech drug developers and technology companies will meet not to only discuss but share real world technical insight and data driven applications of AI and Machine Learning in Drug Development.

At this critical time when AI and Machine Learning technologies promise to revolutionize traditional pharmaceutical practices, gain a competitive advantage by joining the solution led meeting and capitalize on the benefits of AI technologies by:

Download the event brochure here.

Here's what past attendees had to say:

"The information I got was beyond expectation. The case sharing was informative and enlightening. The speakers' cases answered questions that I had before the meeting and inspired me to explore AI in my own work. The Summit also provides adequate time for networking and discussion, which allowed me to exchange ideas and explore future collaboration opportunities." - Sammy Cui, Senior Research Associate, Unilever 

"This conference was very helpful in clarifying challenges and opportunities in this space as it related to our existing and potential future partners. It also had very knowledgeable and enjoyable people to meet." - Ari Allyn-Feuer, University of Michigan Medical School 


Website: http://bit.ly/2PpYny0

Register: http://bit.ly/2DgwtgK

Brochure: http://bit.ly/2Dg8myO

Contact: [email protected], +1-415-735-3289

SOURCE 2nd AI Pharma Innovation: Drug Discovery Summit


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: